Wesana Health Holdings Inc. (C:WESA*CA)

Business Focus: Biotechnology & Medical Research (NEC)

Jun 15, 2022 11:30 am ET
Fresh New Market Movers: Today’s Top Stock Picks for New & Trending Opportunities
Fresh New Market Movers: Today's Top Stock Picks for New & Trending Opportunities
Jun 08, 2022 09:46 am ET
Wesana Health CEO Daniel Carcillo to Keynote Charles River Symposium: Re-Imagining Substance Abuse, Addiction, and Mental Health Disorders with Psychedelic Therapies
Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care paradigms today, is pleased to confirm CEO Daniel...
May 31, 2022 05:30 pm ET
Wesana Announces First Quarter 2022 Financial Results
Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care paradigms today, has today announced its first...
May 10, 2022 07:30 am ET
Wesana Health Outlines Accelerated Drug Development Pathway
Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care paradigms today, is pleased to announce that...
May 05, 2022 09:08 am ET
Wesana Announces Singular Focus on Drug Development Prompting a Strategic Review of its Clinics and Other Care Delivery Assets
Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care paradigms today, is pleased to announce that...
May 02, 2022 10:44 pm ET
Wesana Health Reports Q4 2021 Financial Results and Provides Subsequent Period Highlights
Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care paradigms today, has today announced its fourth...
Apr 29, 2022 08:35 am ET
KCSA Psychedelics Virtual Investor Conference Presentations Now Available for On-Demand Viewing
Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the April 27th and 28th KCSA Psychedelics Virtual Investor Conference are now available for on-demand viewing. REGISTER...
Apr 27, 2022 08:35 am ET
Wesana Health to Present Live at KCSA Virtual Investor Conference April 28th
Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care paradigms today, is pleased to announce that...
Apr 18, 2022 06:34 pm ET
Wesana Is Exploring Broadening SANA-013 Lead Indication to Treat Major Depressive Disorder
Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care paradigms today, is pleased to announce that...
Mar 29, 2022 07:30 am ET
Wesana Health CEO Daniel Carcillo to Speak at Several Leading Investor and Industry Events
Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care paradigms today, is pleased to confirm CEO Daniel...
Mar 22, 2022 07:30 am ET
Wesana Health Announces New Findings Indicating Psylocibin Potentiates Impact of an Anti-Depressant
Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care paradigms today, has announced data from an animal...
Mar 14, 2022 09:07 am ET
Wesana Health Announces Positive Feedback From Pre-IND Meeting With FDA on SANA-013
Wesana Health Holdings Inc.  (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care paradigms today, announced that they have received...
Mar 11, 2022 05:00 pm ET
Wesana Provides Updates on Build-out of Third Clinic
Wesana Health Holdings Inc.  (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care paradigms today, announced today that construction...
Jan 25, 2022 07:30 am ET
Wesana Health Appoints Meghna A. Gaeta as Chief Marketing Officer
Wesana Health Holdings Inc.  (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care paradigms today, announced the appointment of...
Jan 18, 2022 07:30 am ET
Wesana Health Announces Positive Findings From Animal Study on Novel Depression Treatment Protocol Combining Psilocybin and Cannabidiol
Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care paradigms today, has announced positive results of...
Jan 12, 2022 07:00 am ET
Wesana Health Provides Strategic and Operational Updates
Wesana Health Holdings Inc.  (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care paradigms today, is pleased to announce the...
Jan 11, 2022 07:00 am ET
Wesana Health Granted US FDA Pre-IND Meeting for SANA-013
Wesana Health Holdings Inc.  (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care paradigms today, is pleased to announce that the...
Dec 15, 2021 05:13 pm ET
Canadian Securities Exchange's November 2021 Performance Includes Strong Listings Growth and New Financing Milestone
Toronto, Ontario--(Newsfile Corp. - December 15, 2021) - The Canadian Securities Exchange ("CSE" or "the Exchange") today announced its market statistics for the month of November 2021, which was highlighted by near-record listings growth and a new financing milestone.
Dec 14, 2021 07:32 am ET
MAPS and Wesana Health Resume Negotiations
Wesana Health Holdings Inc.  (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company, is pleased to announce receipt of a commercial viability analysis conducted by the Boston Consulting Group (BCG) which...
Dec 09, 2021 07:30 am ET
Wesana Completes Filing of PCT Patents for Novel Drug Protocols
Wesana Health Holdings Inc.  (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company, is pleased to announce that it has filed Patent Cooperation Treaty (“PCT”) patent applications towards securing the exclusive...
Nov 29, 2021 07:05 pm ET
Wesana Health Reports Q3 2021 Financial Results
Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data driven life sciences company, has announced its quarterly financial results for the three- and nine-month period ending September 30, 2021. Q3 2021...
Nov 19, 2021 07:32 am ET
Wesana Health Clinics Surpass 4,000 Administered Ketamine Treatments
Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company, announced today that the Company’s Wesana Clinics business segment has surpassed 4,000 administered ketamine treatments for...
Oct 18, 2021 08:35 am ET
KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand Viewing
NEW YORK, Oct. 18, 2021 /PRNewswire/ -- Virtual Investor Conferences in partnership with KCSA Strategic Communications today announced the presentations from the KCSA Psychedelics Virtual Investor Conference are now available for on-demand viewing.
Oct 18, 2021 08:35 am ET
KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand Viewing
Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view presentations
Oct 11, 2021 09:25 am ET
KCSA Psychedelics Virtual Investor Conference Agenda Announced for October 13th & 14th
Psychedelic and CNS Company Executives share vision, answer questions live at VirtualInvestorConferences.com 
Oct 11, 2021 07:30 am ET
Wesana Health to Present at the KCSA Psychedelics Virtual Investor Conference on October 14th
CHICAGO, Oct. 11, 2021 /PRNewswire/ -- Wesana Health Holdings Inc. ("Wesana" or the "Company") (CSE: WESA; OTCQB: WSNAF), an emerging data driven life sciences company focused on developing innovative approaches for better understanding, protecting and improving neurological health and performance, including through the advancement of psychedelic medicines, today announced that Daniel Carcillo, CEO of Wesana Health, will participate in the KCSA Psychedelics Investor Conference to be held at VirtualInvestorConferences.com on October 13-14, 2021.
Oct 01, 2021 07:30 am ET
Wesana Health Announces Inclusion in the AdvisorShares Psychedelics ETF
Wesana Health Holdings Inc.  (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), an emerging data driven life sciences company focused on developing innovative approaches for better understanding, protecting and improving neurological health and...
Sep 14, 2021 07:30 am ET
Wesana Health Commits Funding of $1.5 Million To Support MAPS’ Research Pipeline
Wesana Health Holdings Inc.  (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), an emerging data-driven life sciences company focused on developing innovative approaches for better understanding, protecting and improving neurological health and...
Sep 09, 2021 07:30 am ET
Wesana Health Announces Closing of PsyTech Acquisition
Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), an emerging data driven life sciences company focused on developing innovative approaches for better understanding, protecting and improving neurological health and...
Aug 31, 2021 07:30 am ET
Distinguished Psychedelic Researcher, Professor of Psychiatry and Neuroscience, Rachel Yehuda, PhD, Joins Wesana Health Scientific Advisory Board
Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), an emerging data driven life sciences company focused on developing innovative approaches for better understanding, protecting and improving neurological health and...
Aug 24, 2021 09:30 am ET
Wesana Health: Early Warning News Release
“Wesana Health Holdings Inc. (“Wesana” or “The Company”)(CSE:WESA; OTCBQB: WSNAF) would like to report that Chad Bronstein (the “Reporter”) of Chicago, Illinois, the Executive Chairman of Wesana Health Holdings Inc. (the “Company”), has filed an...
Aug 19, 2021 07:30 am ET
Wesana Health Highlights Recent Appointments to Board of Directors
Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF) is pleased to highlight the recent appointments of Robert Koffman, MD, MPH; Ian Burnstein; Mitch Kahn and George Michael Steinbrenner IV to its Board of Directors....
Aug 11, 2021 07:30 am ET
Wesana Health Commences Functional Animal Study for Treatment of Traumatic Brain Injury
Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), an emerging data driven life sciences company focused on developing innovative approaches for better understanding, protecting and improving neurological health and...
Aug 02, 2021 09:12 am ET
Wesana Health Announces Listing on OTCQB® Venture Market
Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA), an emerging data driven life sciences company focused on developing innovative approaches for better understanding, protecting and improving neurological health and performance,...
Jul 16, 2021 07:30 am ET
Ian Burnstein Joins Wesana Health Board of Directors
Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA), an emerging data driven life sciences company focused on developing innovative approaches for better understanding, protecting and improving neurological health and performance,...
Jul 14, 2021 08:30 am ET
Psytech To Merge With Wesana; Mycotopia Shareholders Will Benefit From The Transactions
Mycotopia Therapies, Inc., (OTC Pink: TPIA) ("Mycotopia" or the “Company”) announced today that on July 13, 2021 Wesana Health Holdings Inc. (“Wesana”) (CSE: WESA) announced the execution of a definitive agreement to acquire Psychedelitech Inc.,...
Jul 14, 2021 07:30 am ET
Ian Burnstein Joins Wesana Health Advisory Board
Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA), an emerging data driven life sciences company focused on developing innovative approaches for better understanding, protecting and improving neurological health and performance,...
Jul 13, 2021 09:07 am ET
IIROC Trade Resumption - WESA
VANCOUVER, BC, July 13, 2021 /CNW/ - Trading resumes in:
Jul 13, 2021 08:58 am ET
Wesana Health Announces Definitive Agreement to Acquire PsyTech Inc.
Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA), an emerging life sciences company focused on developing innovative approaches for better understanding, protecting and improving neurological health and performance, including...
Jul 13, 2021 08:58 am ET
IIROC Trading Halt - WESA
VANCOUVER, BC, July 13, 2021 /CNW/ - The following issues have been halted by IIROC:
Jun 24, 2021 04:05 pm ET
Wesana Health Partners with University of South Carolina
Wesana Health Holdings Inc. (“Wesana” or the "Company”) (CSE: WESA), an emerging data driven life sciences company focused on developing innovative approaches for better understanding, protecting and improving neurological health and performance,...
Jun 16, 2021 08:30 am ET
CSE Reports Strong Listings Growth in May 2021 Including a Landmark IPO
Toronto, Ontario--(Newsfile Corp. - June 16, 2021) - The Canadian Securities Exchange ("CSE" or "the Exchange") today announced its market statistics for the month of May 2021. The month was highlighted by near-record growth in listings.
Jun 01, 2021 07:37 am ET
Wesana Announces Participation at Upcoming Events in June 2021
Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA), an emerging data driven life sciences company focused on developing innovative approaches for better understanding, protecting and improving neurological health and performance,...
May 27, 2021 08:57 am ET
Renowned Psychedelic Researcher, James Fadiman, PhD, Joins Wesana Health Scientific Advisory Board
Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA), an emerging data driven life sciences company focused on developing innovative approaches for better understanding, protecting and improving neurological health and performance,...
May 21, 2021 07:45 am ET
Wesana Health Expands Research Leadership Team with Mark Wingertzahn, PhD as Chief Scientific Officer
Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA), an emerging data-driven life sciences company focused on developing innovative approaches for better understanding, protecting and improving neurological health and performance,...
May 13, 2021 07:30 am ET
The World Boxing Council and Wesana Health Announce Multi-Year Joint Efforts to Research the Impact of Psychedelics on Traumatic Brain Injury
The World Boxing Council (“WBC”), boxing’s elite sanctioning body, and Wesana Health Holdings Inc. (“Wesana”) (CSE: WESA), an emerging data driven life sciences company focused on developing innovative approaches for better understanding,...
May 10, 2021 07:30 am ET
Wesana Health Commences Trading on the CSE
Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA), formerly Debut Diamonds Inc., is pleased to announce that its shares will commence trading on the Canadian Securities Exchange (“CSE”) today, Monday, May 10, 2021 under the ticker...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.